Bicycle Therapeutics appoints Dr. Arroyo as CDO, promotes Perry to SVP Commercial; CMO leaves

BICYCLE THERAPEUTICS PLC

Santiago Arroyo appointed Chief Development Officer effective March 31, 2023; formerly CMO at Momenta and Fulcrum.
Jennifer Perry promoted to Senior Vice President, Commercial; over 20 years pharma experience in oncology.
Dominic Smethurst, former Chief Medical Officer, has left the company; CEO thanked him for contributions.
Arroyo to oversee pipeline expansion and late-stage development; Perry to build commercial organization.
Company advancing oncology programs BT8009, BT5528, and BT7480 in the clinic.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.